Sio Capital Management’s Cymabay Therapeutics CBAY Stock Holding History

Sio Capital Management’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-555,610	Closed	-$3.48M	–	58
2022 Q4	$3.48M	Hold	555,610	–	–	1.29%	17
2022 Q3	$1.95M	Hold	555,610	–	–	0.62%	25
2022 Q2	$1.64M	Sell	555,610 -6,729	-1%	-$16.1K	0.62%	34
2022 Q1	$1.75M	Hold	562,339	–	–	0.58%	40
2021 Q4	$1.9M	Hold	562,339	–	–	0.57%	44
2021 Q3	$2.05M	Hold	562,339	–	–	0.65%	43
2021 Q2	$2.45M	Hold	562,339	–	–	0.61%	51
2021 Q1	$2.55M	Sell	562,339 -25,000	-4%	-$135K	0.52%	59
2020 Q4	$3.37M	Sell	587,339 -571,897	-49%	-$4.33M	0.69%	51
2020 Q3	$8.39M	Sell	1,159,236 -1,140,746	-50%	-$6.1M	1.66%	21
2020 Q2	$8.03M	Buy	2,299,982 +2,167,508	+1,636%	+$6.25M	2.34%	13
2020 Q1	$196K	Buy	+132,474	New	+$222K	0.07%	64
2019 Q2	–	Sell	-239,827	Closed	-$3.19M	–	90
2019 Q1	$3.19M	Buy	239,827 +52,500	+28%	+$558K	0.86%	47
2018 Q4	$1.47M	Buy	+187,327	New	+$1.78M	0.54%	55
2017 Q4	–	Sell	-75,000	Closed	-$605K	–	67
2017 Q3	$605K	Buy	+75,000	New	+$507K	0.31%	47
2015 Q1	–	Sell	-121,900	Closed	-$1.2M	–	40
2014 Q4	$1.2M	Buy	+121,900	New	+$980K	0.94%	25

Other funds holding CBAY

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sio Capital Management's CBAY Position: Q1 2023 in Review

Sio Capital Management sold out of Cymabay Therapeutics (CBAY) in Q1 2023, closing a stake of 555,610 shares — an estimated $3.48M sold.

Sio Capital Management first reported a position in CBAY in Q4 2014 and held it in 16 quarters. The position peaked at $8.39M in Q3 2020. 139 funds tracked by Wall St. Rank hold CBAY as of Q1 2023.

Sio Capital Management reported no remaining Cymabay Therapeutics position as of Q1 2023 after selling out during the quarter.
Sio Capital Management sold 555,610 Cymabay Therapeutics shares in Q1 2023, an estimated $3.48M.
Sio Capital Management first reported a position in Cymabay Therapeutics in Q4 2014 and held it in 16 quarters.
Sio Capital Management's Cymabay Therapeutics position peaked at $8.39M in Q3 2020.
139 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2023.

Based on Sio Capital Management's 13F filing for Q1 2023, filed 12 May 2023.